Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic

Ichiro Kishimoto1, Hisashi Makino1, Yoko Ohata1

  • 1Department of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Osaka, Japan.

Insights

In patients with type 2 diabetes, higher HbA1c levels predict heart failure (HF) hospitalizations. This risk remains significant even after accounting for other HF risk factors and cardiac abnormalities.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a significant risk factor for developing heart failure (HF).
  • Understanding predictors of HF in diabetic populations is crucial for preventative strategies.

Purpose of the Study:

  • To determine if baseline glycated hemoglobin (HbA1c) predicts heart failure incidence in type 2 diabetes patients.
  • To assess if this association is independent of other established HF risk factors and cardiac structural/functional abnormalities.

Main Methods:

  • Utilized multivariable Cox regression models in a cohort of 608 patients with type 2 diabetes.
  • Examined the association between baseline HbA1c levels and future HF hospitalizations over a median follow-up of 6 years.

Main Results:

  • A 1% increase in baseline HbA1c was associated with a 23% increased hazard ratio for HF hospitalization (HR 1.23, 95% CI 1.1-1.7).
  • This association remained significant after adjusting for age, sex, BMI, blood pressure, and B-type natriuretic peptide (BNP).
  • HbA1c's predictive effect was independent of left ventricular ejection fraction, diastolic function, and coronary heart disease status.

Conclusions:

  • Baseline HbA1c is a significant independent predictor of future heart failure hospitalizations in patients with type 2 diabetes.
  • HbA1c predicts HF risk beyond established markers like BNP and echocardiographic parameters.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
787
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626